BPI-002

N/A

Report date: 2024/04/29 14:58:55
NME

Base Information

Drug NameBPI-002
Drug Alias NameBPI-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeyondSpring Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeyondSpring Pharmaceuticals Inc
Inactive CompaniesChengdu Wanchun Pharmaceutical Co Ltd
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A